Urologic diseases in America project: Benign prostatic hyperplasia

Journal of Urology

Volumn 173, Issue 4, 2005, Pages 1256-1261

  Wei, John T ^a,d   Calhoun, Elizabeth ^b   Jacobsen, Steven J ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Mayo Clinic   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Diagnosis; Economics, medical; Epidemiology; Prostate; Prostatic hyperplasia

Indexed keywords

DOXAZOSIN; FINASTERIDE; TAMSULOSIN; TERAZOSIN;

ABDOMINAL PRESSURE; ADULT; AGED; ARTICLE; BALLOON DILATATION; BLADDER PRESSURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG COST; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INTRAVENOUS UROGRAPHY; LASER SURGERY; LOWER URINARY TRACT SYMPTOM; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION; URINARY TRACT DISEASE; UROFLOWMETRY;

EID: 15044344536     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000155709.37840.fe     Document Type: Article

References (21)

1. Jacobsen, S. J., Guess, H. A., Panser, L., Girman, C. J., Chute, C. G., Oesterling, J. E. et al: A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch Fam Med, 2: 729, 1993
2. Litwin, M. S., Saigal, C. S., Yano, E. M., Avila, C., Geschwind, S. A., Hanley, J. M. et al: Urologic Diseases in America Project: analytic methods and principal findings. J Urol, 173: 933, 2005
3. Litwin, M. S. and Saigal, C. S.: Urologic Diseases in America Interim Compendium. Washington, D. C.: United States Department of Health and Human Services, Public Health Service, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004
4. Platz, E. A., Smit, E., Curhan, G. C., Nyberg, L. M. and Giovannucci, E.: Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U. S. men. Urology, 59: 877, 2002
5. Chute, C. G., Panser, L. A., Girman, C. J., Oesterling, J. E., Guess, H. A., Jacobsen, S. J. et al: The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol, 150: 85, 1993
6. Wei, J. T., Schottenfeld, D., Cooper, K., Taylor, J. M., Faerber, G. J., Velarde, M. A. et al: The natural history of lower urinary tract symptoms in black American men: relationships with aging, prostate size, flow rate and bothersomeness. J Urol, 105: 1521, 2001
7. Girman, C. J., Jacobsen, S. J., Guess, H. A., Oesterling, J. E., Chute, C. G., Panser, L. A. et al: Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol, 153: 1510, 1995
8. Rhodes, T., Girman, C. J., Jacobsen, S. J., Roberts, R. O., Guess, H. A. and Lieber, M. M.: Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. J Urol, 161: 1174, 1999
9. Jacobsen, S. J., Jacobson, D. J., Girman, C. J., Roberts, R. O., Rhodes, T., Guess, H. A. et al: Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol, 102: 1301, 1999
10. Jacobsen, S. J., Jacobson, D. J., Girman, C. J., Roberts, R. O., Rhodes, T., Guess, H. A. et al: Natural history of prostatism: risk factors for acute urinary retention. J Urol, 158: 481, 1997
11. Meigs, J. B., Barry, M. J., Giovannucci, E., Rimm, E. B., Stampfer, M. J. and Kawachi, I.: Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol, 162: 376, 1999
12. Andersen, J. T., Jacobsen, O. and Standgaard, L.: The diagnostic value of intravenous pyelography in infravesical obstruction in males. Scand J Urol Nephrol, 11: 225, 1977
13. McConnell, J. D., Barry, M. J. and Bruskewitz, R. C.: Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research. Clin Pract Guidel Quick Ref Guide Clin, 8: 1, 1994
14. Gee, W. F., Holtgrewe, H. L., Blute, M. L., Miles, B. J., Naslund, M. J., Nellans, R. E. et al: 1997 American Urological Association Gallup survey: changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997. J Urol, 160: 1804, 1998
15. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol, 170: 530, 2003
16. Roehrborn, C. G., Boyle, P., Nickel, J. C., Hoefner, K., Andriole, G., ARIA 3001 et al: Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology, 60: 434, 2002
17. Roehrborn, C. G., Van Kerrebroeck, P. and Nordling, J.: Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies. BJU Int, 92: 257, 2003
18. McConnell, J. D., Roehrborn, C. G., Bautista, O. M., Andriole, G. L., Jr., Dixon, C. M., Kusek, J. W. et al: The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med, 349: 2387, 2003
19. McConnell, J. D., Bruskewitz, R., Walsh, P., Andriole, G., Lieber, M., Holtgrewe, H. L. et al: The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med, 338: 557, 1998
20. Xia, Z., Roberts, R. O., Schottenfeld, D., Lieber, M. M. and Jacobsen, S. J.: Trends in prostatectomy for benign prostatic hyperplasia among black and white men in the United States: 1980 to 1994. Urology, 53: 1154, 1999
21. Boyle, P., Robertson, C., Lowe, F. and Roehrborn, C.: Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int, 93: 751, 2004